Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11457]

Tweaking cancer cell response to ultrasound treatment

Tweaking cancer cell response to ultrasound treatment

Utilising a nanomedicine to achieve tumour catalysis-enhanced differentiation therapy

Utilising a nanomedicine to achieve tumour catalysis-enhanced differentiation therapy

SETDB1 amplification identified as a potential target for new osteosarcoma treatment

SETDB1 amplification identified as a potential target for new osteosarcoma treatment

ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years

ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years

New approach identifies reproducible VOCs for lung cancer diagnosis

New approach identifies reproducible VOCs for lung cancer diagnosis

Immunotherapy against melanoma: efficacy can be predicted with a chip

Immunotherapy against melanoma: efficacy can be predicted with a chip

ASCO GU 2025: Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities

ASCO GU 2025: Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities

ASCO GU 2025: Talazoparib and enzalutamide combination improves survival in some patients with prostate cancer

ASCO GU 2025: Talazoparib and enzalutamide combination improves survival in some patients with prostate cancer

Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escape

Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to...

FDA approves vimseltinib for symptomatic tenosynovial giant cell tumour

FDA approves vimseltinib for symptomatic tenosynovial giant cell tumour

More from ecancer